National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
Dictionary of Cancer Terms
Send to Printer
ZD1839

 A drug that is used to treat certain types of non-small cell lung cancer and is being studied in the treatment of other types of cancer. It is a type of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor. Also called gefitinib and Iressa.

Previous Definitions:yttrium Y 90 SMT 487, Zactima, zafirlukast, Zarnestra, ZD0473
Next Definitions:ZD4054, ZD6474, Zevalin, Zheng, ziconotide